Connective Tissue Dry Needling for Low Back Pain Related to Local Posterior Superior Iliac Spine … (NCT07345871) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Connective Tissue Dry Needling for Low Back Pain Related to Local Posterior Superior Iliac Spine Pain
42 participantsStarted 2026-04-10
Plain-language summary
This single-blind randomized controlled trial will aim to determine the effectiveness of a connective tissue dry needling (CTDN) technique, in reducing pain and improving function in individuals with chronic mechanical low back pain associated with pain and tenderness at the posterior superior iliac spine (PSIS). Forty participants with local PSIS-related low back pain will be recruited and randomly assigned into two groups using the block balanced randomization method. The treatment group will receive CTDN targeting connective tissue trigger points around the PSIS in addition to a sacroiliac joint stabilization exercise program, while the control group will perform the same exercise program alone under the supervision of a physiotherapist. The intervention protocol will span two weeks, during which participants will attend three treatment sessions per week, for a total of six sessions. The primary outcome measurement will use the Visual Analog Scale (VAS) to assess pain intensity. The study will measure secondary outcomes through lumbar range of motion (ROM) in flexion and extension and pressure pain threshold (PPT), and Roland-Morris Disability Questionnaire (RMDQ) functional disability and Short Form-36 (SF-36) health-related quality of life. The researchers will assess all outcomes at three time points: baseline and after the first session, and the sixth session, while VAS will receive an additional assessment at the 3-month follow-up. The findings of this study are expected to provide evidence supporting CTDN as a safe, effective, and cost-efficient treatment option for PSIS-related mechanical low back pain.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Adults aged 18 to 75 years.
. Diagnosed with chronic mechanical low back pain localized at the posterior superior iliac spine region.
. Presence of point tenderness reproducible by palpation at the posterior superior iliac spine area.
. Pain duration of at least two weeks, indicating the non-acute stage of low back pain.
. Negative results in at least three out of five sacroiliac pain provocation tests (Distraction, Compression, Thigh Thrust, Sacral Thrust, Gaenslen).
. Pain intensity ≥ 3 on the Numeric Rating Scale at baseline.
. Ability to communicate and cooperate with the research team during intervention and follow-up.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focusing on pain near the posterior superior iliac spine — could you look at where my low back pain is centered and tell me if that matches the specific area this study is targeting?
2The trial hasn't started recruiting yet — given where I am in my diagnosis, does it make sense to wait and see if this study opens up, or should we be pursuing other treatments in the meantime?
3The trial uses 'connective tissue dry needling,' which sounds different from standard acupuncture or muscle-focused dry needling — can you explain what that technique actually involves and whether you think it's appropriate for my type of low back pain?
4Since this trial is rated Phase NA and is measuring outcomes purely through a pain rating scale, what does that tell us about how much is already known about the safety and effectiveness of this specific needling approach for sacroiliac joint dysfunction?
5If my low back pain is related to sacroiliac joint dysfunction, are there established treatments I should try first, and how would participating in a study like this fit into my overall care plan?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analog Scale
Timeframe: Baseline
2
Visual Analog Scale
Timeframe: 30 minutes
3
Visual Analog Scale
Timeframe: 2 weeks
4
Visual Analog Scale
Timeframe: 3-month follow-up
Trial details
NCT IDNCT07345871
SponsorUniversity of Social Welfare and Rehabilitation Science